EUVIMEDEUVIMED entdecken
Crossref

Rationale and design of a CArdiac Rehabilitation program on the Prevention of CardioTOXicity in Breast Cancer patients undergoing treatment with anthracyclines and/or trastuzumab (CARPTOX-BC) trial: a randomized, active control group, open-label trial

Maria Jose Santa-Ana-Bayona, Camila Ponce-Acosta, Gilberto H Acosta-Gutierrez, Pamela Morales-Alvarez, Enrique C Guerra, Alfonso Gonzalez-Trejo, Jose Rodrigo Espinosa-Fernandez, Nestor J Solis Flores, Hermes Ilarraza-Lomelí, Erick Alexanderson-Rosas, Yoana Leyva-López, Neftali Eduardo Antonio-Villa und 1 weitere

Contemporary Clinical Trials · 2026-08 · 167 · 108385

DOI: 10.1016/j.cct.2026.108385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contemporary Clinical Trials, 2026-08. Verfasst von Maria Jose Santa-Ana-Bayona und 12 weiteren Autor:innen. Beteiligte Einrichtung: Mexican Faculty of Medicine, La Salle University, Mexico City, Mexico. Hauptthemen laut MEDLINE: Breast Neoplasms, Trastuzumab, Anthracyclines, Cardiotoxicity. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Ignacio Chávez National Institute of Cardiology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Breast cancer (BC) remains a leading cause of cancer-related deaths among women. Administration of anthracyclines and/or anti-human epidermal growth factor receptor-2 (HER2) antibodies has been associated with chemotherapy-induced cardiotoxicity. Cardio-oncology rehabilitation programs aim to mitigate these outcomes. However, their preventive role in cancer therapy-related cardiac dysfunction (CTRCD) remains uncertain. OBJECTIVES: To evaluate the effectiveness of a structured exercise program compared with only exercise recommendation in preventing CTRCD, defined by the 2022 European Society of Cardiology criteria, as a left ventricular ejection fraction above 50%, with a relative decrease in global longitudinal strain exceeding 15% from baseline and/or a newly detected elevation in cardiac troponin I or T or natriuretic peptides. Secondary outcomes include the impact on systolic and diastolic echocardiographic parameters, cardiometabolic biomarkers, quality of life, and exploring the role of traditional cardiovascular risk factors in CTRCD onset. METHODS: CARPTOX-BC is a randomized, open-label clinical trial with an active control group. Women aged 18-70 years with stage I-III BC scheduled for neoadjuvant or adjuvant therapy with anthracyclines and/or trastuzumab will be eligible. The intervention includes three supervised out of five weekly aerobic and resistance exercise. A total of 284 participants will be randomized 1:1 to intervention or control arms. RESULTS: Results will be disclosed at completion. CONCLUSIONS: We expect a structured exercise program may reduce the incidence of CTRCD associated with anthracycline and/or HER2 antibody and provide a potential non-pharmacological therapy that could also enhance cardiometabolic markers and quality of life among this population. TRIAL REGISTRATION: NCT06881940 (registered March 18th, 2025).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsTrastuzumabAnthracyclinesCardiotoxicityCardiac RehabilitationExercise TherapyAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleMiddle AgedAdultQuality of LifeAgedRandomized Controlled Trials as TopicStroke VolumeYoung AdultAdolescentAntineoplastic Agents, ImmunologicalGlobal Longitudinal Strain

Stichwörter der Autor:innen

Breast CancerCancer therapy-related cardiac dysfunctionCardiac rehabilitationCardio-oncology

Substanzen

TrastuzumabAnthracyclinesAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Mexican Faculty of Medicine, La Salle University, Mexico City, Mexico.
  • Institute of Biomedical Sciences, Autonomous University of Ciudad Juarez, Ciudad Juarez, Mexico.
  • Department of Echocardiography, National Institute of Cardiology Ignacio Chavez, Mexico City, Mexico.
  • MD-PhD (PECEM) Program, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
  • Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
  • Functional Unit of Breast Tumors, National Institute of Cancerology, Mexico City, Mexico.

Förderung

  • Ignacio Chávez National Institute of Cardiology

Zitieren

APA

Santa-Ana-Bayona, M. J., Ponce-Acosta, C., Acosta-Gutierrez, G. H., Morales-Alvarez, P., Guerra, E. C., Gonzalez-Trejo, A., Espinosa-Fernandez, J. R., Solis Flores, N. J., Ilarraza-Lomelí, H., Alexanderson-Rosas, E., Leyva-López, Y., Antonio-Villa, N. E., & Espinola-Zavaleta, N. (2026). Rationale and design of a CArdiac Rehabilitation program on the Prevention of CardioTOXicity in Breast Cancer patients undergoing treatment with anthracyclines and/or trastuzumab (CARPTOX-BC) trial: a randomized, active control group, open-label trial. Contemporary Clinical Trials, 167, 108385. https://doi.org/10.1016/j.cct.2026.108385

Vancouver

Santa-Ana-Bayona MJ, Ponce-Acosta C, Acosta-Gutierrez GH, Morales-Alvarez P, Guerra EC, Gonzalez-Trejo A, et al. Rationale and design of a CArdiac Rehabilitation program on the Prevention of CardioTOXicity in Breast Cancer patients undergoing treatment with anthracyclines and/or trastuzumab (CARPTOX-BC) trial: a randomized, active control group, open-label trial. Contemporary Clinical Trials. 2026;167:108385. doi:10.1016/j.cct.2026.108385

BibTeX
@article{SantaAnaBayona2026,
  author = {Santa-Ana-Bayona, Maria Jose and Ponce-Acosta, Camila and Acosta-Gutierrez, Gilberto H and Morales-Alvarez, Pamela and Guerra, Enrique C and Gonzalez-Trejo, Alfonso and Espinosa-Fernandez, Jose Rodrigo and Solis Flores, Nestor J and Ilarraza-Lomelí, Hermes and Alexanderson-Rosas, Erick and Leyva-López, Yoana and Antonio-Villa, Neftali Eduardo and Espinola-Zavaleta, Nilda},
  title = {Rationale and design of a CArdiac Rehabilitation program on the Prevention of CardioTOXicity in Breast Cancer patients undergoing treatment with anthracyclines and/or trastuzumab (CARPTOX-BC) trial: a randomized, active control group, open-label trial},
  journal = {Contemporary Clinical Trials},
  year = {2026},
  volume = {167},
  pages = {108385},
  doi = {10.1016/j.cct.2026.108385}
}
Kostenlos starten →